These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 769707)

  • 21. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
    Weinstein A; Rothfield NF
    J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penicillamine in rheumatoid arthritis.
    Hill AG; Hill HF
    Agents Actions Suppl; 1979; (5):129-38. PubMed ID: 393102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial.
    Berry H; Liyanage SP; Durance RA; Barnes CG; Berger LA; Evans S
    Br Med J; 1976 May; 1(6017):1052-4. PubMed ID: 773500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of the efficacy of 2 different doses of D-penicillamine in rheumatoid arthritis].
    Agababova E; Sidel'nikova S; Aseeva E; Nikol'skaia N; Gaziian R
    Ter Arkh; 1981; 53(7):62-7. PubMed ID: 6457408
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical response in relation to dose of penicillamine in the treatment of rheumatoid arthritis.
    Lyle WH
    Int J Clin Pharmacol Res; 1984; 4(6):403-8. PubMed ID: 6533084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose penicillamine treatment of RA. Comparison of 600 mg and 300 mg regimens.
    Nissilä M; Nuotio P; von Essen R; Mäkisara P
    Scand J Rheumatol; 1982; 11(3):161-4. PubMed ID: 6750780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alclofenac and D-penicillamine. Comparative trial in rheumatoid arthritis.
    Berry H; Fernandes L; Ford-Hutchinson AW; Evans SJ; Hamilton EB
    Ann Rheum Dis; 1978 Feb; 37(1):93-7. PubMed ID: 24426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse effects of D-penicillamine in rheumatoid arthritis.
    Stein HB; Patterson AC; Offer RC; Atkins CJ; Teufel A; Robinson HS
    Ann Intern Med; 1980 Jan; 92(1):24-9. PubMed ID: 7350870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-penicillamine: chemistry and clinical use in rheumatic disease.
    Howard-Lock HE; Lock CJ; Mewa A; Kean WF
    Semin Arthritis Rheum; 1986 May; 15(4):261-81. PubMed ID: 2940684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penicillamine treatment in rheumatoid arthritis. A retrospective study.
    Börjesson O; Knutsson LP; Svensson B
    Acta Med Scand; 1980; 207(1-2):93-6. PubMed ID: 7368979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Late results of the D-penicillamine treatment of rheumatoid arthritis].
    Agababova ER; Sidel'nikova SM; Aseeva EM; Nikol'skaia NV; Gaziian RA
    Vopr Revm; 1981; (2):25-7. PubMed ID: 7034367
    [No Abstract]   [Full Text] [Related]  

  • 32. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis.
    Bunch TW; O'Duffy JD; Tompkins RB; O'Fallon WM
    Arthritis Rheum; 1984 Mar; 27(3):267-76. PubMed ID: 6367750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly.
    Kean WF; Anastassiades TP; Dwosh IL; Ford PM; Kelly WG; Dok CM
    J Am Geriatr Soc; 1982 Feb; 30(2):94-100. PubMed ID: 6460054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis.
    Davis P; Bleehen SS
    Br J Dermatol; 1976 Jun; 94(6):705-11. PubMed ID: 779821
    [No Abstract]   [Full Text] [Related]  

  • 37. Penicillamine for rheumatoid arthritis.
    Med Lett Drugs Ther; 1978 Aug; 20(17):73-4. PubMed ID: 355819
    [No Abstract]   [Full Text] [Related]  

  • 38. Reaction to D-penicillamine in rheumatoid arthritis.
    Shafar J; Hollanders D
    Br Med J; 1973 Aug; 3(5874):289. PubMed ID: 4723471
    [No Abstract]   [Full Text] [Related]  

  • 39. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial.
    Brewer EJ; Giannini EH; Kuzmina N; Alekseev L
    N Engl J Med; 1986 May; 314(20):1269-76. PubMed ID: 3517643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
    Munthe E; Kåss E
    J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.